Skip to main content
SpringerLink
Log in

Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Conventional glucocorticoids exert a negative influence on calcium balance, and long-term treatment with these agents leads to osteopenia. Deflazacort is an oxazoline derivative of prednisolone with documented calcium-sparing properties when compared to prednisone on a weight basis. The purpose of the present study was to determine the relative antiinflammatory potency of deflazacort and prednisone. In a randomized, cross-over, double-blind trial, 11 patients, all suffering from polymyalgia rheumatica, and all on a stable maintenance dose of prednisone, were treated with equimolar doses of prednisone and deflazacort (i.e., weight ratio 1∶1.2) for two consecutive 2-week periods. Following deflazacort treatment, significant rises compared with initial values were seen in erythrocyte sedimentation rate (ESR), plasma fibrinogen, serum alkaline phosphatase, and general pain and tenderness. No changes were seen following prednisone treatment. Subsequently, in a similar regimen, prednisone was compared with deflazacort at a weight ratio of 1∶1.2 in 10 patients, 1∶1.5 in another 10 patients, and 1∶1.8 in still another 10 patients for purposes of dose titration. Again, significant rises were seen in ESR, plasma fibrinogen, and serum alkaline phosphatase following the lowest dose of deflazacort, whereas no changes were seen following the higher doses of deflazacort or prednisone. In conclusion, the relative antiinflammatory potency of deflazacort and prednisone lies between 0.83 and 0.66 on a weight basis (1.02 and 0.82 on a molar basis) as evaluated by clinical and biochemical parameters reflecting disease activity in polymyalgia. This disease appears to represent a sensitive, reliable and reproducible clinical model for assessment of the relative antiinflammatory potency of glucocorticoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lund B, Pedersen JG, Egsmose C, Lund B (1984) In vitro evidence of the calcium-sparing effect of deflazacort. Adv Exp Med Biol 171:149–154

    PubMed  CAS  Google Scholar 

  2. Gennari C (1981) Comparative evaluation of the effect of a new synthetic glucocorticoid (deflazacort, DL 458) on mineral and bone metabolism during subacute and prolonged treatment. Int Symposium on Corticoids and the Metabolism of Calcium and Phosphorus, Prague (Abstract 15)

  3. Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV (1984) Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 36:245–252

    Article  PubMed  CAS  Google Scholar 

  4. Lo Cascio V, Bonucci E, Imbimbo B, Ballanti P, Tartarotti D, Galvanini G, Fuccella L, Adami S (1984) Bone loss after glucocorticoid therapy. Calcif Tissue Int 36:435–438

    Article  PubMed  Google Scholar 

  5. Gennari C, Imbimbo B (1985) Effects of prednisone and deflazacort on vertebral bone mass. Calcif Tissue Int 37:592–593

    PubMed  CAS  Google Scholar 

  6. Bonucci E, Lo Cascio V (1985) Histomorphometry and bioumoral data. Proc 2nd Int. Colloquium on Glucocorticoid Effects, Malta, October 1985

  7. Nagant de Deuxchaisnes C, Devogelaer JP, Huaux JP, Dufour JP, Esselinckx W, Stasse P (1986) The effect of small equivalent doses of deflazacort and prednisone on the bone mineral content in male patients with rheumatoid arthritis (Abstract) American Society for Bone and Mineral Research, Anaheim, June 21–24, 1986

  8. Pagano G, Cavallo-Perin P, Bruna A, Lombardi A, Ozzello A, Dall'Omo AM, Imbimbo B (1984) Deflazacort versus prednisone: diabetogenic effect evaluated by glucose clamp and compartmental analysis. Adv Exp Med Biol 171:45–51

    PubMed  CAS  Google Scholar 

  9. Cavallo-Perin P, Bruno A, Ozzello A, et al. (1984) Comparison of acute and subacute effects of deflazacort and prednisone on glucose metabolism in man. Eur J Clin Pharmacol 26:357–362

    Article  PubMed  CAS  Google Scholar 

  10. Imbimbo B, Tuzi T, Porzio F, Schiavetti L (1984) Clinical equivalence of a new glucocorticoid, deflazacort and prednisone, in rheumatoid arthritis and S.L.E. patients. Adv Exp Med Biol 171:241–256

    PubMed  CAS  Google Scholar 

  11. Marcolongo R (1979) Comparative study of the effects of a new synthetic corticosteroid (deflazacort, DL 458) in prolonged combined treatment of rheumatoid arthritis in the active and maintenance stage. Internal report D.R.C., Le Petit Research Laboratories

  12. Longhi A (1978) Comparative clinical trial of the effects of two steroids (DL 458 and prednisone) in acute and chronic skin diseases. Internal report D.R.C. no. 166, Le Petit Research Laboratories

  13. Allegra F (1978) Comparative clinical trial of two glucocorticoids (DL 458-IT and prednisone) in the treatment of acute and chronic skin diseases. Internal report D.R.C. no. 167, Le Petif Research Laboratories

  14. Bird HA, Esselinck W, Dixon AStJ, Mowat AG, Wood PHN (1979) An evaluation of criteria for polymyalgia rhematica. Ann Rheum Dis 38:434–439

    Article  PubMed  CAS  Google Scholar 

  15. Oriente P, Pucino A, Scarpa R, Vignone L (1985) Deflazacort versus prednisone nelle connecttiviti sistemiche: valutazione del rapporto di potenza. Proc 2nd Int Colloquium on Glucocorticoid Effects, Malta, October 1985

  16. Colombo B, Sinigaglia L, Cagnoli M, Imbimbo B (1985) Comparison between deflazacort and methylprednisolone in 16 patients with rheumatoid arthritis. Proc 2nd Int Colloquium on Glucocorticoid Effects, Malta, October 1985

  17. Numo R (1985) A cross-over study on deflazacort (DL) and methylprednisolone (MP) in rheumatoid arthritis patients for clinical equivalence. Proc 2nd Int Colloquium on Glucocorticoid Effects, Malta, October 1985

  18. Munno OD, Beghe F, Milani S, Imbimbo B, Pasero G (1985) Confronto tra deflazacort e metilprednisolone nell'arterite reumatoide. Proc 2nd Int Colloquium on Glucocorticoid Effects, Malta, October 1985

  19. Marcolongo R, Frati E, Negrine S, Biasi G (1985) Studio comparativo sull'efficacia e sulla potenza terapeutica del deflazacort e del metilprednisolone nell'artrite reumatoide. Proc 2nd Int Colloquium on Glucocorticoid Effects, Malta, October 1985

  20. Buniva G, Dubini A, Sasella D (1979) Human bioassay of corticotropin-suppressing, eosinopenic and hyperglycaemic potencies of deflazacort and prednisone. Curr Therap Res 26:69–81

    CAS  Google Scholar 

  21. Crisculo D, Fraioli F, Bonifacio V, Paolucci D, Isidori A (1980) Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: a comparison with prednisone. Int J Clin Pharmacol Biopharm 18:37–41

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark

    B. Lund, C. Egsmose, S. Jørgensen & M. R. Krogsgaard

  2. Department of Rheumatology, Hvidovre Hospital, Copenhagen, Denmark

    B. Lund, C. Egsmose, S. Jørgensen & M. R. Krogsgaard

Authors
  1. B. Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Egsmose
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Jørgensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. R. Krogsgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lund, B., Egsmose, C., Jørgensen, S. et al. Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica. Calcif Tissue Int 41, 316–320 (1987). https://doi.org/10.1007/BF02556669

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02556669

Key words

Search

Navigation